Toward a chronotherapy of ovarian cancer with taxol. Part I: Basic background.
University of Minnesota, Minneapolis.
G
G
Cornélissen
E
E
Halberg
H J
HJ
Long
K
K
Prem
E
E
Bakken
Y
Y
Touitou
S
S
Elg
E
E
Haus
F
F
Halberg
D000470:Alkaloids / Q000008:administration & dosage* / Q000009:adverse effects; D000818:Animals; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects; D014408:Biomarkers, Tumor / Q000097:blood; D002909:Chronobiology Phenomena; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood / Q000188:drug therapy*; D017239:Paclitaxel
D000470:Alkaloids; D015295:Antigens, Tumor-Associated, Carbohydrate; D000972:Antineoplastic Agents, Phytogenic; D014408:Biomarkers, Tumor; D017239:Paclitaxel